H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.184 HKD -0.54%
Market Cap: 92.1m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Huakang Biomedical Holdings Co Ltd

Revenue
25.1m CNY
Cost of Revenue
-8.7m CNY
Gross Profit
16.4m CNY
Operating Expenses
-22.9m CNY
Operating Income
-6.5m CNY
Other Expenses
416k CNY
Net Income
-6.1m CNY

Income Statement
Huakang Biomedical Holdings Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Jun-2024
Revenue
Revenue
27
N/A
26
-3%
25
-2%
22
-12%
21
-6%
21
+1%
22
+4%
25
+13%
27
+9%
26
-2%
26
-1%
27
+4%
26
-5%
26
+2%
25
-4%
25
-1%
25
-1%
24
-3%
25
+1%
25
+2%
Gross Profit
Cost of Revenue
(7)
(7)
(8)
(7)
(6)
(7)
(7)
(8)
(10)
(10)
(10)
(10)
(9)
(9)
(8)
(8)
(8)
(9)
(9)
(9)
Gross Profit
20
N/A
19
-6%
18
-5%
16
-12%
15
-7%
15
0%
15
+1%
17
+13%
17
+3%
17
-3%
16
-1%
17
+2%
17
-2%
17
+5%
17
-2%
17
+0%
17
-1%
16
-7%
16
+2%
16
+3%
Operating Income
Operating Expenses
(16)
(17)
(18)
(19)
(22)
(22)
(23)
(25)
(23)
(23)
(20)
(20)
(20)
(20)
(21)
(21)
(21)
(21)
(22)
(23)
Selling, General & Administrative
(14)
(16)
(16)
(18)
(20)
(21)
(21)
(21)
(19)
(18)
(18)
(18)
(18)
(18)
(19)
(19)
(19)
(19)
(20)
(20)
Research & Development
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(3)
(2)
(3)
(3)
(3)
(3)
(3)
Other Operating Expenses
0
0
0
0
0
0
0
(3)
(3)
(3)
1
1
1
1
0
0
1
0
0
0
Operating Income
4
N/A
2
-61%
0
-97%
(4)
N/A
(7)
-89%
(8)
-11%
(8)
+1%
(9)
-9%
(6)
+30%
(6)
-4%
(4)
+40%
(3)
+16%
(3)
-4%
(3)
+4%
(4)
-35%
(4)
+3%
(5)
-16%
(6)
-23%
(6)
-10%
(7)
-2%
Pre-Tax Income
Interest Income Expense
(0)
0
1
2
1
(0)
(1)
(1)
(1)
(1)
(0)
(0)
0
1
1
1
1
0
1
0
Non-Reccuring Items
(5)
(4)
0
0
0
0
(3)
0
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(1)
N/A
(2)
-58%
1
N/A
(2)
N/A
(6)
-187%
(8)
-36%
(11)
-37%
(10)
+14%
(7)
+26%
(7)
+2%
(4)
+45%
(3)
+13%
(3)
+19%
(2)
+28%
(3)
-51%
(3)
+5%
(4)
-27%
(5)
-48%
(6)
-8%
(6)
-7%
Net Income
Tax Provision
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
Income from Continuing Operations
(2)
(3)
(0)
(3)
(7)
(9)
(12)
(10)
(8)
(7)
(4)
(4)
(3)
(2)
(3)
(3)
(4)
(5)
(6)
(6)
Net Income (Common)
(2)
N/A
(3)
-19%
(0)
+89%
(3)
-917%
(7)
-129%
(9)
-31%
(12)
-34%
(10)
+13%
(8)
+24%
(7)
+4%
(4)
+43%
(4)
+11%
(3)
+17%
(2)
+22%
(3)
-26%
(3)
+5%
(4)
-23%
(5)
-40%
(6)
-15%
(6)
-6%
EPS (Diluted)
-0.01
N/A
-0.01
N/A
0
N/A
-0.01
N/A
-0.02
-100%
-0.02
N/A
-0.03
-50%
-0.03
N/A
-0.02
+33%
-0.02
N/A
-0.01
+50%
-0.01
N/A
-0.01
N/A
-0.01
N/A
-0.01
N/A
-0.01
N/A
-0.01
N/A
-0.01
N/A
-0.01
N/A
-0.01
N/A

See Also

Discover More